Voyager Therapeutics, Inc. SEC filings VYGR
Voyager Therapeutics, Inc. has 681 filings in SEC EDGAR's recent list, going back to Apr 23, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 21, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 12, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Other events
|
May 16, 2024 | May 16, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 13, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Jan 2, 2024 | Dec 28, 2023 |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 16, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Other events
|
Jul 10, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Officer or director change
|
May 9, 2023 | May 6, 2023 |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 24, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Jan 9, 2023 | Jan 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Other events
|
Oct 4, 2022 | Oct 4, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 23, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 7, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 20, 2022 | Apr 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2022 | Mar 19, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Officer or director change
|
May 19, 2021 | May 14, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Agreement ended, Other events
|
Feb 2, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2021 | Jan 15, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2020 | Sep 14, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Agreement ended
|
Aug 3, 2020 | Jul 28, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Results of operations
|
May 6, 2020 | May 6, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 19, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2020 | Mar 3, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 9, 2019 | Aug 9, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 17, 2019 | Jun 14, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2019 | Jun 13, 2019 |
| 8-K |
Current report
Officer or director change
|
May 21, 2019 | May 20, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Other events
|
Mar 12, 2019 | Mar 11, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2019 | Feb 26, 2019 |
| 8-K |
Current report
Material agreement
|
Feb 22, 2019 | Feb 21, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 29, 2019 | Jan 28, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2018 | Nov 7, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2018 | Aug 7, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2018 | Jun 28, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2018 | Jun 14, 2018 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2018 | Jun 1, 2018 |
| 8-K |
Current report
Officer or director change
|
May 29, 2018 | May 22, 2018 |
| 8-K |
Current report
Results of operations
|
May 10, 2018 | May 10, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Material agreement
|
Feb 20, 2018 | Feb 16, 2018 |
| 8-K |
Current report
Material agreement
|
Feb 7, 2018 | Feb 5, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2018 | Jan 31, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 8, 2017 | Nov 7, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2017 | Nov 2, 2017 |
| 8-K |
Current report
Officer or director change
|
Sep 18, 2017 | Sep 18, 2017 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2017 | Aug 8, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2017 | Jun 19, 2017 |
| 8-K |
Current report
Results of operations
|
May 9, 2017 | May 9, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2017 | Mar 15, 2017 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2017 | Jan 5, 2017 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2017 | Jan 1, 2017 |
| 8-K |
Current report
Other events
|
Dec 7, 2016 | Dec 7, 2016 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2016 | Nov 10, 2016 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2016 | Oct 18, 2016 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2016 | Aug 11, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2016 | Jun 15, 2016 |
| 8-K |
Current report
Results of operations
|
May 12, 2016 | May 12, 2016 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2016 | Mar 17, 2016 |
| 8-K |
Current report
Results of operations
|
Dec 17, 2015 | Dec 17, 2015 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 16, 2015 | Nov 16, 2015 |
Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VYGR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1640266
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.